[1] Becker MJ,de Marie S,Willemse D,et al.Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an expergillosis in an experimental rat model[J].J Clin Miembiol,2000,38(4):1434-1438. [2] Elston MS,Gill AJ,Conaglell JV,et al.Nuclear accumulation of e-cadherin correlates with loss of cytoplasmicmembrane staining and invasion in pituitary adenomas[J].J Clin Endocrinol Metab,2009,94(4):1436-1442. [3] Verdaguer V,Walsh TJ,Hope W,et al.Galactomannan antigen detection in the diagnosis of invasive aspergillosis[J].Expert Rev Mol Diagn,2007,7(1):21-32. [4] Metindir J,DilekGB,Pak Ⅰ.Staining characterization by immunohistochemistry of tumor cancer antigen in patients with endometrial[J].Ear J Gynaecol Oncol,2008,29(5):489-492. [5] Kauffmann-Lacroix C,Rodier MH,Jacquemin JL,et al.Detection of galactomannan for diagnosis of fongal rhinosinusitis[J].J Clin Micmbiol,2001,39(12):4593-4594. [6] Maertens J,Verhaegen J,Demuynck H,et al.Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis[J].J Clin Microbiol,1999,37(10):3223-3228. [7] Kawazu M,Kanda Y,Nannya Y,et al.Prospective comparison of the diagnostic potential of real-time PCR,double-sandwich enzyme-linked immunosorbent assay for galactomannan,and a(1-3)-β-D-glucan test in weekly sceening for invasive aspergillosis in patients with hematological disorders[J].J Clin Microbiol,2004,42(6):2733-2741. [8] Rex JH.Galactomannan and the diagnosis of invasive aspergillosis[J].Clin Infect Dis,2006,42(15):1428-1430. [9] Mattei D,Mordini N,Lo Nigro C,et al.Galactomannan antigenemia for early diagnosis and treatment of invasive aspergillosis:three years singal centre experience(abstract 3632),San Diego,CA,2003[C].In Proceedings 45th ASH 2003. [10] 余进,李若瑜.侵袭性烟曲霉菌感染早期诊断的实验研究[J].中华检验医学杂志,2003,26(9):534-536. [11] Maertens JA,Theunissen K,Verbeken E,et al.Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and hematological stem cell recipients[J].Br J Haematol,2004,126(6):852-860. [12] Herbreeht R,Letseher-Bru V,Oprea C,et al.Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients[J].J Clin Oncol,2002,20(7):1898-1906. [13] 唐晓丹,汪复.半乳甘露聚糖试验诊断侵袭性曲霉菌病的评价--一项荟萃分析[J].中困感染与化疗杂志,2007,7(1):8. [14] Zaas,Aimee K,Alexander,et al.Galactomannan and advances in fungal diagnostics[J].Current Opinion in Organ Transplantation,2005,10(4):307-311. [15] Musher B,Fredrieks D,Leisenring W,et al.Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid[J].J Clin Microbiol,2004,42(12):5517-5522. [16] Maertens J,Verhaegen J,Lagrou K,et al.Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutmpenic patients and stem cell transplantation recipients:a prospective validation[J].Blood,2001,97:1604-1610. [17] Boutboul F,Alberti C,Leblane T,et al.Invasive aspergillosis in allogeneic stem cell transplant recipients:increasing antigenemia is associated with progressive disease[J].Clin Infect Dis,2002,34:939-943. [18] Pferffer CD,Fine JP,Safdar N.Diagonsis of invasive aspergillosis using a galactomannan assay:a meta-analysis[J].Clin Infect Dis,2006,42(15):1417-1427. [19] 石岩,刘大为.隆云,等.血清半乳甘露聚糖在重症患者肺部曲霉菌感染分级诊断中的作用[J].中华内科杂志2009,48(3):225-230. [20] Wheat LJ.Rapid diagnosis of invasive aspergillus antigen detection[J].Transplant Infectious Disease,2003,5(4):158-166. [21] Metan G,Durusu M,Uzun O.False positivity for Aspergillus antigenemia with amoxicillin-clavulonic acid[J].J Clin Microbiol,2005,43(5):2548. [22] Fortún J,Martín-Dávila P,Alvarez ME,et al.False-Positive results of aspergillus galactomannan antigenemia in liver transplant recipicents[J].Transplantation,2009,87(2):256-260. [23] Sulahian A,Touratier S,Ribaud P.False positive test for Aspergillus antigenemia related to concmitant administration of piperacillin and tazobactam[J].N Engi J Med,2003,349(24):2366-2367. [24] Viscoli M,Machetti M,Cappellano P,et al.False-positive galactomannan Platelia Aspergillus test results for patients receiving piperacillin-tazobactam[J].Clin Infect Dis,2004,38(6):913-916. [25] Adam O,Auperin A,Wilquin F,et al.Treatment with piperacillin-tazobactam and false positive Asporgillus galactomannan antigen test results for patients with hematological malignancies[J].Clin Infeet Dis,2004,38(6):917-920. [26] Machetti M,Majabo MJ,Furfaro E.Kinetics of galactomannan in surgical patients receiving perioperative piperaeillin/tazobactam prophylaxis[J].J Antimicrob Chemother,2006,58(4):806-810. [27] Mennink-Kersten MA,Donnelly JP,Verweij PE.Detection of circulating galactomannan for the diagnosis and management of invasive asporgillosis[J].Lancet Infect Dis,2004,4(6):349-357. [28] 郝飞.侵袭性真菌感染非培养快速诊断方法的评价[J].中华检验医学杂志,2003,26(9):524-526. [29] Denning DW.Early diagnosis of invasive aspergillosis[J].Lancet,2000,355(9202):423-424. [30] 熊祝嘉,徐迎春.半乳甘露聚糖用于侵袭性曲霉感染实验诊断的研究现状[J].中国真菌学杂志,2007,2(1):52-54. [31] 金欣.陈建魁,于农,等.血液病患者深部曲霉菌感染的血清学诊断[J].中国卫生检验杂志,2009,19(12):2857-2858. |